Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-17

FDA Approved: FULVESTRANT — Original Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approves Accord Healthcare's Original Application for a generic fulvestrant (Fulvestrant) for the treatment of metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fulvestrant (fulvestrant)

Snippet

ORIG AP for FULVESTRANT (FULVESTRANT)